Quanterix Corp cash flow statement
In fiscal 2025, Quanterix Corp's operations generated −$77.2m of cash; it spent $2.6m on capital projects, leaving free cash flow of −$79.8m.
Cash flow statement
| Fiscal year | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −18 | −22 | −29 | −26 | −23 | −48 | −49 | −19 | −35 | −77 | −81 |
| Depreciation and amortisation | 0 | 0 | 1 | 3 | 4 | 5 | 5 | 6 | 6 | 16 | 23 |
| Stock-based pay | 1 | 2 | 5 | 6 | 10 | 16 | 15 | 17 | 20 | 21 | 19 |
| Capital spending | 1 | 1 | 2 | 11 | 4 | 14 | 12 | 4 | 3 | 3 | 1 |
| Free cash flow | −18 | −23 | −30 | −37 | −27 | −61 | −60 | −23 | −39 | −80 | −82 |
| Free cash flow after stock pay | −19 | −25 | −35 | −43 | −37 | −77 | −76 | −40 | −59 | −101 | −100 |
| Shares issued | 45 | 8 | −0 | — | — | — | — | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −6 | −4 | −14 | −6 | −41 | −16 | −18 | −5 |
| Depreciation and amortisation | 2 | 2 | 2 | 2 | 5 | 6 | 6 | 6 |
| Stock-based pay | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 4 |
| Capital spending | 1 | 0 | 1 | 1 | 1 | −0 | 0 | 0 |
| Free cash flow | −7 | −5 | −15 | −6 | −42 | −16 | −18 | −5 |
| Free cash flow after stock pay | −11 | −10 | −21 | −12 | −47 | −21 | −23 | −9 |
Compare with peers
- Pacific Biosciences Of California, Inc. cash flow
- Grail, Inc. cash flow
- Cryoport, Inc. cash flow
- Cytek Biosciences, Inc. cash flow
- Maravai Lifesciences Holdings, Inc. cash flow
Head to head: PACB vs QTRXGRAL vs QTRXCYRX vs QTRX
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies